Related Experiment Videos
Intrinsically radiopaque hydrogels for nucleus pulposus replacement
Erik J H Boelen1, Catharina S J van Hooy-Corstjens, Sjoerd K Bulstra
1Center for Biomaterials Research, University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands. E.Boelen@bioch.unimaas.nl
Biomaterials
|June 7, 2005
Summary
New hydrogels show promise for treating degenerative disc disease by replacing the nucleus pulposus. These biomaterials are non-cytotoxic, possess suitable mechanical properties, and offer adequate radiopacity for effective treatment.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Spine Surgery
Background:
- Intervertebral disc degeneration is a primary cause of back pain.
- Current treatments may involve nucleus pulposus replacement while preserving the annulus fibrosus.
Purpose of the Study:
- To develop and evaluate novel hydrogel biomaterials for nucleus pulposus replacement.
- To assess hydrogels based on radiopacity, cytotoxicity, in situ swelling, and mechanical properties.
Main Methods:
- Synthesized eight hydrogel copolymers using 2-(4'-iodobenzoyl)-oxo-ethyl methacrylate (4IEMA) with N-vinyl-2-pyrrolidinone (NVP) or 2-hydroxyethyl methacrylate (HEMA).
- Investigated copolymerization via 1H-NMR, and evaluated swelling, mechanical properties, in vitro cytotoxicity, and X-ray contrast.
- Tested hydrogels with varying 4IEMA compositions (5, 10, 15, 20 mol%).
Main Results:
- Hydrogels containing 5 mol% 4IEMA demonstrated non-cytotoxicity.
- These hydrogels exhibited adequate physical-mechanical properties matching native nucleus pulposus.
- Sufficient radiopacity was observed in a realistic model for the 5 mol% 4IEMA hydrogels.
Conclusions:
- Hydrogels with 5 mol% 4IEMA meet key criteria for nucleus pulposus replacement.
- These findings suggest a potential new treatment strategy for degenerative disc disease.